Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy
NCT07555301
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
IgA Nephropathy (IgAN)
Interventions
DRUG:
sparsentan
DRUG:
sparsentan
Sponsor
Waid City Hospital, Zurich